This research focuses on strengthening fragile mRNA molecules to create vaccines that are more stable, effective, and easier to distribute. By modifying mRNA structure to resist degradation, vaccines could be stored at higher temperatures and maintain potency, expanding access—especially in low-resource regions—and improving global readiness for future pandemics.

This research targets the earliest stage of allergic and asthmatic immune reactions by blocking key cytokine “messages” sent from T cells to B cells. Using drug-discovery techniques, the project identifies compounds that prevent immune overreaction before symptoms begin, aiming to develop a new class of long-lasting preventative allergy and asthma treatments.

My research presents a self-administered microneedle patch made from hyaluronic acid that delivers vaccines quickly, painlessly, and effectively. Testing with a COVID-19 spike RBD antigen shows immune responses comparable to traditional injections. The patches are low-risk, easy to use, and can be stored at room temperature for a month—ideal for widespread vaccination.